MACROPHAGE RECRUITMENT IN NERVOUS SYSTEM INJURY & REPAIR
Project Number5R01NS037428-02
Contact PI/Project LeaderGRIFFIN, JOHN W
Awardee OrganizationJOHNS HOPKINS UNIVERSITY
Description
Abstract Text
During nerve fiber degeneration in the peripheral nervous system monocytes are promptly, abundantly, and selectively recruited from the circulation, myelin debris is rapidly cleared, and, presumably in part as a result of macrophage contributions, regeneration (in the rodent) is rapid and extensive. In contrast, during fiber degeneration in the central nervous system (CNS) hematogenous monocytes fail to be recruited, and CNS myelin debris, known to be inimical to axonal outgrowth, is cleared very slowly. Several lines of evidence have raised the possibility that the presence of macrophages within degenerating CNS pathways might increase the likelihood of successful axonal elongation. Recent data from the Griffin and Ransohoff labs suggest that a product of denervated Schwann cells, the C-C chemokine, monocyte chemoattractant protein-1 (MCP-1), provides one important mechanism. The overall goals of this project are: To understand fully the mechanism(s) by which monocytes are recruited into the degenerating PNS and to develop preparations that fail to recruit macrophages during Wallerian degeneration, focusing initially on the hypothesis that activation of the MCP-1 receptor CCR2 is necessary and sufficient to recruit hematogenous monocytes; and to test the hypothesis that providing the degenerating CNS with the capability to recruit circulating monocytes will result in prompt clearance of myelin debris and increased axonal regeneration. The planned studies will characterize the chemokine profiles produced by Schwann cells during Wallerian degeneration, and determine whether MCP-1 and CCR2 knockouts are unable to recruit macrophages normally. We will test a widely cited hypothesis, that complement activation occurs on PNS myelin during Wallerian degeneration, so that complement activation products are chemotropic to macrophages. The final series of experiments will characterize chemokine production and macrophage recruitment in the dorsal columns and the optic nerves of normal mice during Wallerian degeneration, and compare the results to those in transgenic mice in which MCP-1 expression is governed by the GFAP promotor. We anticipate that abundant macrophage recruitment will be seen during CNS fiber degeneration in these animals, and that CNS myelin debris will be rapidly cleared. Such animals will provide the ideal system in which to test the possibility that CNS regeneration will be substantially improved by permitting macrophage recruitment.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
axoncellular immunitycytokine receptorsgene targetinggenetically modified animalsimmunosuppressionlaboratory mousemacrophagemacrophage activating factormicrogliamonocytemonocyte chemoattractant protein 1myelinnerve injurynervous system regenerationoligodendrogliaoptic nerveperipheral nervous systemtransfectionwallerian degeneration
National Institute of Neurological Disorders and Stroke
CFDA Code
854
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
01-March-1999
Project End Date
28-February-2002
Budget Start Date
01-March-2000
Budget End Date
28-February-2001
Project Funding Information for 2000
Total Funding
$176,902
Direct Costs
$107,867
Indirect Costs
$69,035
Year
Funding IC
FY Total Cost by IC
2000
National Institute of Neurological Disorders and Stroke
$176,902
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS037428-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS037428-02
Patents
No Patents information available for 5R01NS037428-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS037428-02
Clinical Studies
No Clinical Studies information available for 5R01NS037428-02
News and More
Related News Releases
No news release information available for 5R01NS037428-02
History
No Historical information available for 5R01NS037428-02
Similar Projects
No Similar Projects information available for 5R01NS037428-02